Prev Arrow Stocks

Align Technology Inc. ($ALGN) Stock Forecast: Down 5.0% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Align Technology Inc.?

A company known for its Invisalign product, Align Technology, Inc. (NASDAQ: ALGN) specializes in clear aligner therapy, with a focus on global markets and innovation for growth.

Why is Align Technology Inc. going down?

ALGN stock is down 5.0% on Apr 30, 2026 14:01

  • Despite exceeding Q1 2026 expectations with robust revenue and earnings growth, Align Technology (ALGN) faced a downturn in the market.
  • Positive sentiment towards the company is highlighted by Mizuho increasing the stock price target and maintaining an Outperform rating based on strong case volume growth.
  • A 2% revenue decrease, attributed to weakened demand in North America, may have contributed to the market decline despite the reaffirmed full-year guidance.
  • Concerns over geopolitical tensions and rising operating expenses possibly led to investor apprehension, resulting in the bearish market movement.

ALGN Price Chart

ALGN Technical Analysis

ALGN News

Align Technology, Inc. (NASDAQ:ALGN) Q1 2026 Earnings Call Transcript

Align Technology (NASDAQ:ALGN) reported better-than-expected Q1 2026 results, with revenues of $1.04 billion, Clear Aligner volumes up 6.7% year-over-year, and diluted EPS of $2.58. The company emphasized strong growth in international markets and DSOs, strategic initiatives like the doctor subscription program and patient financing, and continued investment in innovation such as direct fabrication and the iTero Lumina ecosystem. Despite macroeconomic uncertainties and potential impacts from the Middle East conflict, Align reaffirmed its full-year 2026 guidance, projecting 3% to 4% revenue growth and an improved non-GAAP operating margin of approximately 23.7%.

https://www.insidermonkey.com/blog/align-technology-inc-nasdaqalgn-q1-2026-earnings-call-transcript-1751030/

0 News Article Image Align Technology, Inc. (NASDAQ:ALGN) Q1 2026 Earnings Call Transcript

Mizuho raises Align Technology stock price target on strong case volume

Mizuho has increased its price target for Align Technology (NASDAQ:ALGN) to $220 from $215, maintaining an Outperform rating. This elevation follows impressive first-quarter 2026 results where Invisalign case volume grew 7% year-over-year, exceeding market estimates, and earnings per share rose 21%. The company's strong performance, particularly in international markets, has led to a 29% stock price gain over the past six months and a positive outlook for future growth.

https://www.investing.com/news/analyst-ratings/mizuho-raises-align-technology-stock-price-target-on-strong-case-volume-93CH-4648095

1 Missing News Article Image Mizuho raises Align Technology stock price target on strong case volume

Mizuho raises Align Technology stock price target on strong case volume

Mizuho increased its price target for Align Technology (NASDAQ:ALGN) to $220 from $215, maintaining an Outperform rating, following strong Q1 2026 results. The company reported a 7% increase in Invisalign case volume and a 21% rise in EPS year-over-year, driven by international markets. Mizuho also raised its EPS estimates for 2026 and 2027 based on optimistic guidance for future clear aligner volume.

https://m.investing.com/news/analyst-ratings/mizuho-raises-align-technology-stock-price-target-on-strong-case-volume-93CH-4648095?ampMode=1

2 Missing News Article Image Mizuho raises Align Technology stock price target on strong case volume

Align Technology Stock (US0162551016): Reports Q1 2026 Results with 2% Revenue Decline

Align Technology Inc. reported Q1 2026 results with revenues of $956.7 million, a 2% year-over-year decline attributed to softer demand in North America. Despite this, the company reaffirmed its full-year guidance for 2026. The article highlights the company's business model, key products like Invisalign and iTero scanners, and its position in the expanding clear aligner market.

https://www.ad-hoc-news.de/boerse/news/ueberblick/align-technology-stock-us0162551016-reports-q1-2026-results-with-2/69262523

3 News Article Image Align Technology Stock (US0162551016): Reports Q1 2026 Results with 2% Revenue Decline

Align Technology Inc (ALGN) Q1 2026 Earnings Call Highlights: Re

Align Technology Inc (ALGN) reported strong Q1 2026 results with record revenues of $1.041 billion, driven by a 6.2% year-over-year increase, and clear aligner shipments growing by 6.7%. The company expanded its digital platform and announced a $200 million share repurchase plan, demonstrating confidence in its business fundamentals. Despite growth, ALGN faces challenges including potential impacts from Middle East geopolitical tensions, a decline in North American clear aligner volumes, and increased operating expenses.

https://www.gurufocus.com/news/8831043/align-technology-inc-algn-q1-2026-earnings-call-highlights-record-revenue-and-strategic-growth-amid-global-challenges

4 Missing News Article Image Align Technology Inc (ALGN) Q1 2026 Earnings Call Highlights: Re

Align Technology Inc. Price History

24.01.2026 - ALGN Stock was up 5.2%

  • ALGN stock saw a significant bullish movement recently.
  • The company's strategic focus on digital workflows, international expansion, and targeting large dental networks appears to have excited investors.
  • The integration of Align Technology's iTero intraoral scanners with Henry Schein One's Dentrix practice management platforms is viewed positively for streamlining digital workflows in dental practices, potentially boosting long-term profitability.
  • Align Technology's attention to children's early dental habits demonstrates its dedication to promoting oral health, which could enhance its brand reputation and customer loyalty.

01.03.2026 - ALGN Stock was up 5.9%

  • ALGN stock showed significant bullish momentum.
  • Wealth Enhancement Advisory Services LLC and Polianta Ltd both raised their holdings in ALGN, signaling faith in the company's growth.
  • Strong quarterly earnings exceeded analyst forecasts, contributing to the market's positive response.
  • A legal win for Sight Sciences against Alcon potentially bolstered investor confidence in ALGN, underscoring the importance of intellectual property protection in healthcare.

10.02.2026 - ALGN Stock was up 5.0%

  • Fieldview Capital Management LLC and Rhenman & Partners Asset Management AB acquiring additional shares of ALGN indicate confidence in the company's future prospects, contributing to the bullish movement.
  • The robust growth of the Invisible Orthodontic Appliance Market, in which Align Technology is a key player, is driving investor optimism and interest in the stock.
  • Despite recent share price pullbacks, ALGN's strong earnings performance, expanding clinical indications for Invisalign, and expected double-digit earnings growth are factors supporting the bullish trend.
  • The company's higher-than-industry-average P/E ratio and potential valuation risk if market sentiment shifts highlight the need for investors to monitor market dynamics closely despite the current positive momentum.

08.03.2026 - ALGN Stock was up 6.9%

  • ALGN experienced significant bullish movement today, possibly driven by its inclusion in Evercore ISI's "Tactical Outperform" list and the reaffirmation of an Outperform rating with a $200 price target.
  • Recent earnings beats, revenue growth, and net income increases, alongside analyst upgrades, have reignited investor interest in ALGN, contributing to its positive performance in the market.
  • Despite concerns about overvaluation, a Discounted Cash Flow (DCF) model suggests undervaluation, which could appeal to investors seeking opportunities based on financial health and valuation metrics.

27.02.2026 - ALGN Stock was down 7.4%

  • ALGN was removed from the FTSE All-World Index, impacting passive investment flows and liquidity, potentially affecting institutional investor exposure.
  • A realignment by Vanguard resulted in 0% ownership of ALGN shares, signaling a change in their investment strategy.
  • The stock underperformed compared to competitors in a market downturn, trading below its 52-week high achieved in July.
  • Reports of Elliott Investment Management taking a large position in ALGN led to a jump in shares, indicating potential changes or shareholder activism that could have influenced the market movement.

27.02.2026 - ALGN Stock was down 6.1%

  • The stock of this company mirrored the downward trend of the market today.
  • Market volatility due to geopolitical tensions and policy uncertainties influenced the drop in the company's shares.
  • Factors like increasing oil prices and concerns about extended conflicts negatively affected consumer confidence, resulting in significant decreases in premium stocks such as this company.
  • Despite the market decline, potential investment opportunities may arise for those interested in long-term holdings of high-quality stocks like this company.

27.02.2026 - ALGN Stock was down 7.1%

  • The bearish movement in ALGN stock today could be attributed to the significant reduction in stake by Riverbridge Partners LLC, selling 119,935 shares in Q4, which might have raised concerns among investors about the company's growth prospects.
  • Additionally, the removal of ALGN from the FTSE All-World Index could have impacted passive investment flows and liquidity, leading to selling pressure on the stock as large institutional investors adjust their exposure to the company.
  • The realignment of Vanguard's holdings, with ALGN now showing 0% ownership, might have added to the negative sentiment around the stock as investors react to changes in major institutional positions.
  • Despite ALGN recently surpassing analyst expectations for earnings and revenue, these external factors such as stake sell-offs and index removal could have overshadowed the positive performance, contributing to the bearish market movement today.

17.02.2026 - ALGN Stock was up 6.0%

  • Analysts have upgraded Align Technology from Equal-Weight to Overweight, setting a price target of $200. This upgrade signifies a higher level of confidence in the company's market standing and its potential for future success.
  • Despite concerns about sluggish organic revenue growth and difficulties in the Asia Pacific region, Align Technology has shown strong performance, including impressive Q4 results and outperforming the Nasdaq. These factors have contributed to its positive market movement.
  • By organizing the Southeast Asia Forum to address dental innovation and trends, Align Technology is demonstrating its dedication to advancing dental health and strengthening its presence in the region. This initiative has bolstered investor optimism about the company's growth prospects.
  • The underperformance of Cooper Companies (COO) in comparison to Align Technology and the overall market might have prompted investors to shift their focus towards Align Technology, thereby fueling its positive market trend.

17.02.2026 - ALGN Stock was up 6.3%

  • The recent Southeast Asia Forum showcased (ALGN)'s dedication to dental innovation and collaboration with medical experts, boosting investor confidence in its leadership in the dental technology sector.
  • The positive market outlook for digital dentistry, with its rapid expansion and potential, may have influenced the bullish movement in (ALGN)'s stock. Investors seem optimistic about the company's growth in this thriving sector.
  • While some dental companies face performance challenges, (ALGN)'s strategic focus on advancing dental health through initiatives like the Southeast Asia Forum has positioned it well in the market. This commitment to innovation likely contributed to today's bullish performance.

30.03.2026 - ALGN Stock was down 5.0%

  • Despite exceeding Q1 2026 expectations with robust revenue and earnings growth, Align Technology (ALGN) faced a downturn in the market.
  • Positive sentiment towards the company is highlighted by Mizuho increasing the stock price target and maintaining an Outperform rating based on strong case volume growth.
  • A 2% revenue decrease, attributed to weakened demand in North America, may have contributed to the market decline despite the reaffirmed full-year guidance.
  • Concerns over geopolitical tensions and rising operating expenses possibly led to investor apprehension, resulting in the bearish market movement.

28.03.2026 - ALGN Stock was down 5.0%

  • The bearish movement in ALGN today can be attributed to the company underperforming compared to its competitors. This consistent decline over the past few days has likely raised concerns among investors.
  • Despite the positive sentiment from retail investors anticipating a rally into 2026, the stock took a hit after missing earnings expectations and receiving a downgrade from Morgan Stanley. This negative news likely weighed heavily on the stock price.
  • The upcoming earnings report might have also influenced investor sentiment, with expectations of revenue growth being closely watched. Any deviation from these expectations could have contributed to the bearish movement witnessed today.

14.03.2026 - ALGN Stock was up 6.8%

  • Despite encountering competitive pressures and economic factors, ALGN's stock surged by 4.35%, surpassing the overall market performance.
  • The utilization of the company's exclusive software and iTero scanners, which drive recurring revenue, likely influenced investor confidence.
  • The stock's positive momentum possibly reflects investors' realization of ALGN's undervaluation, supported by a GF Value of $250.42 and a robust GF Score of 94/100.
  • In essence, ALGN's strong upward movement today highlights its ability to withstand competition and market obstacles, possibly driven by solid fundamentals and positive investor sentiment.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.